Pressrelease – Lund, September 21st 2026 – Hamlet BioPharma’s monthly digital investors’ meeting on September 23rd

Hamlet Biopharma
|
September 21, 2026

Hamlet BioPharma invites you to our monthly investors’ meeting to be held on September 23rd 2026, at 12:00.

Please click on the link below to participate in the meeting

https://us06web.zoom.us/j/88380550798?pwd=Q4a214z0Kt50CaT6GWkhGphlQmjZgv.1

 

For further information, please contact

Jakob Testad, CFO, Hamlet BioPharma AB, +46 708 48 42 10
jakob.testad@hamletbiopharma.com

Catharina Svanborg, CEO, Hamlet BioPharma AB, +46 709 42 65 49
catharina.svanborg@hamletpharma.com

www.hamletbiopharma.com

 

An innovative pharmaceutical company with a broad and strong portfolio of projects for the treatment of cancer and infections.
Hamlet BioPharma AB
Klinikgatan 32
SE-222 42 Lund
info@hamletbiopharma.com
Org. no. 556568-8958
Subscribe to receive
Pressreleases and Newsletters
© 2026
Hamlet BioPharma.